HAE
Haemonetics Corporation
106.80$
-1.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.0% | 13.4% | 18.0% | 24.4% | 16.5% | 16.0% | 12.5% | 17.3% | 23.4% | 13.9% | 13.4% | 22.0% | |
| 9.5% | 9.9% | 10.1% | 9.9% | 11.3% | 11.2% | 9.7% | 9.8% | 8.0% | 7.4% | 8.5% | 8.4% | |
| 1.5% | 0.8% | 1.0% | 1.4% | 1.8% | 2.1% | 2.9% | 2.5% | 2.2% | 2.2% | 2.2% | 2.5% | |
| 2.9% | 12.5% | 10.2% | 0.6% | 6.0% | 6.5% | 0.5% | 4.7% | 3.1% | – | – | – | |
| -0.4% | -2.2% | -0.1% | 8.5% | -6.5% | -8.6% | -6.9% | -1.5% | 2.2% | -4.8% | -6.8% | -1.8% | |
| 13.4% | 11.3% | 8.6% | 8.3% | 12.3% | 4.9% | 4.3% | 9.7% | 9.4% | 2.9% | 2.9% | 2.5% | |
| -13.4% | -11.5% | -8.3% | -7.0% | -12.0% | -5.8% | -48.9% | -8.7% | -12.3% | -24.6% | -11.9% | -13.5% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 1.4% | 1.2% | – | – | 0.6% | – | – | – | |
| -4.3% | -6.7% | 3.7% | -11.1% | -16.5% | -17.7% | 1.2% | -7.6% | -6.4% | -0.4% | -16.5% | -13.1% | |
| -1.1% | -2.2% | -10.5% | -6.7% | 9.9% | 3.2% | 42.6% | -1.8% | 23.0% | 2.9% | 32.9% | -0.5% | |
| -3.6% | -6.9% | -6.8% | -13.3% | -5.2% | -13.3% | 42.2% | -1.6% | -8.6% | 2.9% | 8.0% | -13.4% | |
| -3.5% | -5.0% | 2.8% | 4.5% | -1.1% | -3.2% | 6.3% | 6.8% | 2.1% | -8.1% | 9.4% | -4.6% | |
| 0.5% | 2.1% | 9.4% | 16.1% | 4.2% | 11.1% | 8.2% | 7.6% | 13.9% | 11.0% | 10.5% | 19.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.